SCHEMBL14713247

SCHEMBL14713247

CC(C)CC(O)(Cc1ccccc1)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.46
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
SLC6A2 P23975 3/20 0.41
TAAR1 Q96RJ0 3/20 0.41
FDPS P14324 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.39
LMNA P02545 1/20 0.38
CYP2D6 P10635 1/20 0.38
HIF1A Q16665 1/20 0.37
MAOA P21397 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
CYP2A6 P11509 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4445459 0.88 TRPA1 (0.52) TRPA1CYP1A2CYP2C9CYP2C19SLC6A2
SCHEMBL14713913 0.82 TRPA1 (0.47) TRPA1CYP1A2CYP2C9CYP2C19SLC6A2
SCHEMBL23277194 0.80 TRPA1 (0.48) TRPA1CYP1A2CYP2C9CYP2C19SLC6A2
SCHEMBL19329098 0.78 TRPA1 (0.52) TRPA1CYP1A2CYP2C9CYP2C19SLC6A2
SCHEMBL14511604 0.78 TRPA1 (0.52) TRPA1CYP1A2CYP2C9CYP2C19SLC6A2
SCHEMBL1152085 0.76 TRPA1 (0.48) TRPA1CYP1A2CYP2C9CYP2C19SLC6A2
SCHEMBL607846 0.76 TRPA1 (0.48) TRPA1CYP1A2CYP2C9CYP2C19SLC6A2
SCHEMBL27350008 0.75 TRPA1 (0.47) TRPA1CYP1A2CYP2C9CYP2C19SLC6A2
Hydrochloric Acid SCHEMBL8841085 0.74 TRPA1 (0.47) TRPA1CYP1A2CYP2C9CYP2C19SLC6A2
Hydrochloric Acid SCHEMBL8841084 0.74 TRPA1 (0.47) TRPA1CYP1A2CYP2C9CYP2C19SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859777-B2 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators KINENTIA BIOSCIENCES LLC (US) 2014-10-14 US disclosed
US-20130045165-A1 4-FLUORO-4-ARYLPIPERDIN-1-YL DERIVATIVES AS MU OPIOID FUNCTION MODERATORS KINENTIA BIOSCIENCES, LLC (US) 2013-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130045165-A1 4-FLUORO-4-ARYLPIPERDIN-1-YL DERIVATIVES AS MU OPIOID FUNCTION MODERATORS OPRD1, OPRK1, OPRM1 TRPA1 140/4885CYP1A2 521/4885CYP2C9 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.